Connect with us

Hi, what are you looking for?

Monday, Mar 24, 2025

Mugglehead Investment Magazine

Alternative investment news based in Vancouver, B.C.

Mugglehead Investment Magazine

All posts tagged "Summit Therapeutics"

H.C. Wainwright raises share target price for Instil Bio by US$15

H.C. Wainwright raises share target price for Instil Bio by US$15

Medical and Pharmaceutical

H.C. Wainwright raises share target for Instil Bio by US$15

Instil Bio stock rose by nearly 57% on Thursday due to this prediction and other recent developments

Rowan DunneSeptember 12, 2024

Summit Therapeutics up 65% as lung cancer drug outperforms Merck's

Summit Therapeutics up 65% as lung cancer drug outperforms Merck's

Medical and Pharmaceutical

Summit Therapeutics up 55% as lung cancer drug outperforms Merck’s

Analysts have now given the company a much higher share target price too

Rowan DunneSeptember 9, 2024

More Posts